Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Silvis › NPI 1427132604
Transport

Genesis Health System

Genesis Health System was paid $2.35M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 53% of everything it billed.

33Billing provider infoGENESIS HEALTH SYSTEM
SILVIS, IL 61282
33aNPI1427132604assigned 10/25/2006
33bProvider typeAmbulance
28Total paid$2.35M
24GClaims77,882
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ambulance providers in Illinois

Rank by total paid#33 of 137
Median peer was paid$601K
This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201814,975$548K
201926,377$742K
202012,921$333K
202110,360$334K
20227,054$269K
20234,307$93K
2024incomplete1,888$27K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 53% 12,838 2,003 $1.24M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 21% 12,047 11,694 $504K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 6.0% 1,927 1,889 $141K
97161 4.2% 942 618 $99K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.3% 2,970 2,920 $54K
83655 1.6% 3,448 3,340 $38K
80053 Comprehensive metabolic panel 1.1% 4,740 4,258 $26K
77067 Screening mammography, bilateral, including computer-aided detection <1% 448 430 $23K
84443 Thyroid stimulating hormone (TSH) <1% 2,366 2,201 $19K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 931 854 $18K
97162 <1% 166 95 $18K
80061 Lipid panel <1% 2,564 2,444 $16K
83 more codes
86738 <1% 1,546 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,114 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,113 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,115 $11K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 838 $11K
87081 <1% 1,962 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,951 $6K
99214 Doctor's office visit, returning patient (more involved) <1% 132 $5K
99222 Initial hospital care, per day, moderate complexity <1% 56 $5K
80048 Basic metabolic panel (calcium, ionized) <1% 955 $4K
85027 <1% 1,787 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 22 $4K
71046 Radiologic examination, chest; 2 views <1% 459 $3K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 2,595 $3K
84439 <1% 1,000 $3K
87480 <1% 632 $3K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 283 $3K
87510 <1% 632 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 467 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 28 $2K
87186 <1% 435 $2K
99232 Hospital visit by a doctor, follow-up day <1% 36 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 47 $2K
A0425 Ground mileage, per statute mile <1% 132 $2K
85018 <1% 1,205 $1K
87340 <1% 542 $1K
87660 <1% 619 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 761 $983.62
99284 Emergency room visit (serious) <1% 12 $931.52
86580 <1% 327 $927.08
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 108 $874.71
86787 <1% 384 $863.20
86480 <1% 24 $859.30
86592 <1% 1,013 $750.43
87400 <1% 262 $687.27
86141 <1% 133 $682.29
99283 Emergency room visit (moderate) <1% 13 $638.52
86901 <1% 581 $637.81
81001 <1% 1,333 $634.57
36415 Collection of venous blood by venipuncture <1% 221 $634.35
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 17 $583.78
86762 <1% 484 $531.33
82950 <1% 569 $500.90
82607 <1% 114 $492.53
87581 <1% 14 $480.76
86850 <1% 576 $472.09
90460 Immunization administration through 18 years of age via any route, first or only component <1% 12 $452.64
85610 <1% 418 $449.26
80076 <1% 67 $376.96
86900 <1% 578 $307.90
82728 <1% 212 $289.71
83615 <1% 234 $213.15
87070 <1% 106 $196.82
83540 <1% 220 $168.92
83735 <1% 292 $162.83
83550 <1% 114 $151.83
81003 <1% 212 $112.40
84702 <1% 45 $96.17
83718 <1% 12 $88.11
87420 <1% 16 $84.04
84156 <1% 190 $72.80
82570 <1% 98 $72.63
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 13 $54.92
82947 <1% 86 $53.94
82465 <1% 12 $46.75
84460 <1% 47 $40.39
83021 <1% 14 $35.58
87077 <1% 73 $26.55
82248 <1% 27 $24.66
82977 <1% 29 $23.74
76937 <1% 23 $23.11
85007 <1% 50 $22.65
84450 <1% 29 $17.22
86337 <1% 15 $17.22
82565 <1% 13 $13.62
82247 <1% 12 $12.11
82043 <1% 30 $11.52
85660 <1% 14 $9.08
85730 <1% 12 $8.58
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 201 $0.00
36416 0% 18 $0.00
99001 0% 108 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 194 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROGERS, MARK (INTERIM CFO)
Same official

Other billing entities under ROGERS, MARK

Full network →
ProviderLocationPaid
Genesis Health SystemDavenport, IA$9.12M
Genesis Health SystemSilvis, IL$4.03M
Genventures, INC.Davenport, IA$3.34M
Genesis Health SystemDe Witt, IA$1.95M
Genventures, INC.Davenport, IA$246K
Central Utah Foot Clinic, LLCProvo, UT$39K
Genesis Health SystemErie, IL$21K
Genventures, INC.Moline, IL$14K
Genventures, INC.Davenport, IA$8K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.